Stock Events

Stock Events

Dianthus Therapeutics 

$106.73
17
-$4.81-4.31% 18:01 Today

Statistics

Day High
111.31
Day Low
106.73
52W High
117.88
52W Low
22.81
Volume
159,504
Avg. Volume
1,060,223
Mkt Cap
5.97B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.07
-0.98
-0.9
-0.81
Expected EPS
-0.987092
Actual EPS
N/A

Financials

-7,973.33%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
2.04MRevenue
-162.34MNet Income

Analyst Ratings

136.82Average Price Target
The highest estimate is 200.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DNTH. It's not an investment recommendation.
NVIDIA
2
NVDA
Bitcoin
2
BTC.CRYPTO
Meta Platforms
2
META
Lilly(Eli) &
2
LLY

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Show more...
CEO
Marino Garcia
Employees
92
Country
United States
ISIN
US2528281080
WKN
000A3ERZ4

Listings

XETRA
DE
87E.XETRA
STU
DE
87E.STU
MU
DE
3MT.MU
STU
DE
3MT.STU

0 Comments

Share your thoughts

FAQ

What is Dianthus Therapeutics stock price today?▼
The current price of DNTH is $106.73 USD — it has decreased by -4.31% in the past 24 hours. Watch Dianthus Therapeutics stock price performance more closely on the chart.
What is Dianthus Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Dianthus Therapeutics stocks are traded under the ticker DNTH.
Is Dianthus Therapeutics stock price growing?▼
DNTH stock has fallen by -3.11% compared to the previous week, the month change is a +5.93% rise, over the last year Dianthus Therapeutics has showed a +333.86% increase.
What is Dianthus Therapeutics market cap?▼
Today Dianthus Therapeutics has the market capitalization of 5.97B
When is the next Dianthus Therapeutics earnings date?▼
Dianthus Therapeutics is going to release the next earnings report on November 05, 2026.
What were Dianthus Therapeutics earnings last quarter?▼
DNTH earnings for the last quarter are -0.9 USD per share, whereas the estimation was -0.85 USD resulting in a -6.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Dianthus Therapeutics revenue for the last year?▼
Dianthus Therapeutics revenue for the last year amounts to 2.04M USD.
What is Dianthus Therapeutics net income for the last year?▼
DNTH net income for the last year is -162.34M USD.
How many employees does Dianthus Therapeutics have?▼
As of August 28, 2026, the company has 92 employees.
In which sector is Dianthus Therapeutics located?▼
Dianthus Therapeutics operates in the Health & Wellness sector.
When did Dianthus Therapeutics complete a stock split?▼
The last stock split for Dianthus Therapeutics was on September 12, 2023 with a ratio of 1:16.
Where is Dianthus Therapeutics headquartered?▼
Dianthus Therapeutics is headquartered in NEW YORK, United States.